Brief: Galectin Reports Positive Outcome Of Its First Data And Safety Monitoring Board Meeting For Navigate
14/04/2022 13:16
April 14 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS INC - REPORTED POSITIVE OUTCOME OF
ITS
FIRST DATA AND SAFETY MONITORING BOARD (DSMB) MEETING FOR
NAVIGATE
* GALECTIN THERAPEUTICS INC - BASED ON ITS DELIBERATION,
DSMB
CONCLUDED THAT NAVIGATE CAN CONTINUE AS DESIGNED, WITHOUT
MODIFICATIONS
Source text for Eikon: ID:nGNX5BV5Q0
Further company coverage: GALT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study